Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-200
Closed -$132 948
2024
Q4
$132 Hold
200
﹤0.01% 856
2024
Q3
$170 Hold
200
﹤0.01% 850
2024
Q2
$133 Hold
200
﹤0.01% 837
2024
Q1
$260 Hold
200
﹤0.01% 756
2023
Q4
$115 Hold
200
﹤0.01% 844
2023
Q3
$151 Hold
200
﹤0.01% 815
2023
Q2
$146 Hold
200
﹤0.01% 806
2023
Q1
$151 Sell
200
-69
-26% -$64 ﹤0.01% 754
2022
Q4
$258 Hold
269
﹤0.01% 729
2022
Q3
$1K Hold
269
﹤0.01% 733
2022
Q2
$1K Hold
269
﹤0.01% 747
2022
Q1
$1K Hold
269
﹤0.01% 705
2021
Q4
$2K Hold
269
﹤0.01% 680
2021
Q3
$2K Buy
+269
New +$2.21K ﹤0.01% 671

Other funds holding VXRT

PSI Advisors's VXRT Position: Q1 2025 in Review

PSI Advisors sold out of Vaxart (VXRT) in Q1 2025, closing a stake of 200 shares — an estimated $132 sold.

PSI Advisors first reported a position in VXRT in Q3 2021 and held it in 14 quarters. The position peaked at $2K in Q4 2021. 92 funds tracked by Wall St. Rank hold VXRT as of Q1 2025.

  • PSI Advisors reported no remaining Vaxart position as of Q1 2025 after selling out during the quarter.
  • PSI Advisors sold 200 Vaxart shares in Q1 2025, an estimated $132.
  • PSI Advisors first reported a position in Vaxart in Q3 2021 and held it in 14 quarters.
  • PSI Advisors's Vaxart position peaked at $2K in Q4 2021.
  • 92 funds tracked by Wall St. Rank held Vaxart as of Q1 2025.

Based on PSI Advisors's 13F filing for Q1 2025, filed 21 Apr 2025.